National Research (NRC) to Announce Earnings on Tuesday

Posted by Brian Himes on Jul 21st, 2026

National Research (NASDAQ:NRC – Get Free Report) is expected to be announcing its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect National Research to post earnings of ($0.15) per share and revenue of $34.90 million for the quarter. Interested persons may review the information on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Tuesday, July 28, 2026 at 10:00 AM ET.

National Research (NASDAQ:NRC – Get Free Report) last released its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. The firm had revenue of $34.80 million for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

National Research Stock Performance

Shares of NRC opened at $21.41 on Tuesday. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52. National Research has a one year low of $11.01 and a one year high of $23.00. The firm has a market capitalization of $487.08 million, a P/E ratio of 54.90 and a beta of 0.35. The business has a fifty day moving average of $20.14 and a 200 day moving average of $18.22.

Institutional Investors Weigh In On National Research

Several hedge funds and other institutional investors have recently modified their holdings of NRC. AQR Capital Management LLC lifted its holdings in National Research by 86.2% during the second quarter. AQR Capital Management LLC now owns 201,396 shares of the company’s stock valued at $3,383,000 after purchasing an additional 93,262 shares in the last quarter. Heartland Advisors Inc. purchased a new stake in shares of National Research in the fourth quarter worth $938,000. Jane Street Group LLC increased its stake in shares of National Research by 394.2% in the first quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock worth $671,000 after purchasing an additional 41,806 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its position in shares of National Research by 180.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 49,076 shares of the company’s stock valued at $627,000 after purchasing an additional 31,599 shares during the period. Finally, Two Sigma Investments LP raised its position in shares of National Research by 99.0% during the 3rd quarter. Two Sigma Investments LP now owns 60,912 shares of the company’s stock valued at $778,000 after purchasing an additional 30,296 shares during the period. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on NRC shares. Weiss Ratings raised National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 29th. Citizens Jmp began coverage on shares of National Research in a research report on Monday, June 22nd. They set a “market outperform” rating and a $23.00 price target for the company. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $23.00.

Get Our Latest Report on NRC

National Research Company Profile

(Get Free Report)

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.